Market Blog

Agios Pharma & Eleven Biotherepeutics driven by sentiments

AGIO – Agios Pharmaceuticals, Inc is a biopharmaceutical company, engaged in the discovery and development of medicines for the treatment of cancer and genetic disorders. AGIO – Agios Pharmaceuticals, Inc Fundamentals Previously closed at 50.35 Day's high 55.96 Day's low 50.02 P/E ratio NA EPS -3.62   Analysts opinion Agios Pharma announced positive results for its phase 1 Drug AG-348, used to treat anaemia. The stock was upgraded by Canaccord